New York State Common Retirement Fund
ELVN icon

New York State Common Retirement Fund’s Enliven Therapeutics ELVN Stock Holding History

New York State Common Retirement Fund’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52M Buy
38,648
+29,551
+325% +$819K ﹤0.01% 1495
2025
Q4 		$140K Sell
9,097
-6,000
-40% -$120K ﹤0.01% 2453
2025
Q3 		$309K Buy
15,097
+5,300
+54% +$107K ﹤0.01% 2112
2025
Q2 		$197K Hold
9,797
– – ﹤0.01% 2262
2025
Q1 		$193K Sell
9,797
-15,226
-61% -$328K ﹤0.01% 2246
2024
Q4 		$563K Sell
25,023
-2,488
-9% -$64.5K ﹤0.01% 1903
2024
Q3 		$703K Buy
27,511
+4,341
+19% +$101K ﹤0.01% 1808
2024
Q2 		$541K Buy
23,170
+13,795
+147% +$290K ﹤0.01% 2015
2024
Q1 		$165K Sell
9,375
-24
-0.3% -$368 ﹤0.01% 2532
2023
Q4 		$130K Sell
9,399
-54
-0.6% -$661 ﹤0.01% 2636
2023
Q3 		$129K Buy
9,453
+253
+3% +$4.26K ﹤0.01% 2615
2023
Q2 		$188K Buy
+9,200
New +$186K ﹤0.01% 2525
2021
Q3 		– Sell
-16
Closed -$1K – 3390
2021
Q2 		$1K Sell
16
-1,584
-99% -$49.1K ﹤0.01% 3393
2021
Q1 		$54K Hold
1,600
– – ﹤0.01% 3200
2020
Q4 		$141K Buy
1,600
+475
+42% +$39.9K ﹤0.01% 2884
2020
Q3 		$92K Hold
1,125
– – ﹤0.01% 2953
2020
Q2 		$124K Buy
+1,125
New +$126K ﹤0.01% 2848

Other funds holding ELVN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

New York State Common Retirement Fund's ELVN Position: Q1 2026 in Review

New York State Common Retirement Fund increased its Enliven Therapeutics (ELVN) stake by 325% in Q1 2026, buying an estimated $819K and bringing the position to 38,648 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1495.

New York State Common Retirement Fund first reported a position in ELVN in Q2 2020 and has held it in 17 quarters since. 170 funds tracked by Wall St. Rank hold ELVN as of Q1 2026.

  • New York State Common Retirement Fund held 38,648 shares of Enliven Therapeutics worth $1.52M as of Q1 2026.
  • New York State Common Retirement Fund bought 29,551 Enliven Therapeutics shares in Q1 2026, an estimated $819K.
  • Enliven Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #1495 holding.
  • New York State Common Retirement Fund first reported a position in Enliven Therapeutics in Q2 2020 and has held it in 17 quarters since.
  • 170 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.